InMode Ltd. Ordinary Shares (NASDAQ: INMD)
The Complaint alleges that during the Class Period, Defendants made materially false and misleading statements and omissions related to: (1) the price at which it sells its devices, which reflects the demand for those products; and (2) its compliance with FDA regulations, including the FDA’s prohibition on off-label marketing of devices and the FDA’s requirements for the reporting of injuries.